Century Therapeutics, Inc.
IPSC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850119
In the last 90 days, Century Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $387.0M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Century Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 57
- −8 vs. Q2 2025
- Shares held
- 20.3M
- −2.31M (−10.2%) vs. Q2 2025
- Total value
- $10.1M
- −$2.52M (−19.9%) vs. Q2 2025
- New holders
- 5
- 9 more added
- Sold out
- 13
- 29 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IPSC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 100 | $387.0M |
| Q1 2026 | 72 | $315.6M |
| Q4 2025 | 47 | $25.6M |
| Q3 2025 | 57 | $10.1M |
| Q2 2025 | 65 | $12.6M |
| Q1 2025 | 70 | $14.1M |
| Q4 2024 | 72 | $36.8M |
| Q3 2024 | 67 | $67.8M |
| Q2 2024 | 61 | $102.3M |
| Q1 2024 | 67 | $96.6M |
| Q4 2023 | 63 | $58.7M |
| Q3 2023 | 55 | $36.1M |
| Q2 2023 | 64 | $61.0M |
| Q1 2023 | 64 | $69.5M |
| Q4 2022 | 65 | $107.2M |
| Q3 2022 | 54 | $208.7M |
| Q2 2022 | 56 | $182.8M |
| Q1 2022 | 52 | $278.9M |
| Q4 2021 | 50 | $335.2M |
| Q3 2021 | 49 | $496.2M |
| Q2 2021 | 36 | $490.8M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Century Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,538,609 | $1.76M | 0.12% | −1,871,752−34.6% | Reduced |
| Renaissance Technologies LLC | 2,586,900 | $1.29M | 0.00% | +564,400+27.9% | Added |
| Vanguard Group Inc | 2,103,869 | $1.05M | 0.00% | −6,213−0.3% | Reduced |
| DAFNA Capital Management LLC | 1,704,232 | $848.7K | 0.21% | 00.0% | Unchanged |
| Casdin Capital, LLC | 1,228,190 | $611.6K | 0.05% | 00.0% | Unchanged |
| Syncona Portfolio Ltd | 1,213,056 | $604.1K | 2.18% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 911,446 | $453.9K | 0.00% | +338,902+59.2% | Added |
| Tang Capital Management LLC | 900,000 | $448.2K | 0.02% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 857,600 | $427.1K | 0.00% | +490,500+133.6% | Added |
| Millennium Management LLC | 743,781 | $370.4K | 0.00% | −68,432−8.4% | Reduced |
| Acadian Asset Management LLC | 719,808 | $357.0K | 0.00% | +412,711+134.4% | Added |
| Gsa Capital Partners LLP | 603,479 | $301.0K | 0.03% | +136,873+29.3% | Added |
| BlackRock, Inc. | 599,656 | $298.6K | 0.00% | −325,027−35.2% | Reduced |
| Superstring Capital Management LP | 462,963 | $230.6K | 0.23% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 445,309 | $221.8K | 0.00% | +65,032+17.1% | Added |
| Citadel Advisors LLC | 360,825 | $179.7K | 0.00% | +174,291+93.4% | Added |
| Squarepoint Ops LLC | 236,053 | $117.6K | 0.00% | +195,573+483.1% | Added |
| FMR LLC | 192,139 | $95.7K | 0.00% | −828,475−81.2% | Reduced |
| State Street Corp | 127,443 | $63.5K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 91,323 | $45.5K | 0.00% | 00.0% | Unchanged |
| Wealth Enhancement Advisory Services, LLC | 77,853 | $43.5K | 0.00% | −3,394−4.2% | Reduced |
| Susquehanna International Group, LLP | 67,924 | $33.8K | 0.00% | −132,027−66.0% | Reduced |
| Northern Trust Corp | 67,000 | $33.4K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 60,682 | $30.2K | 0.00% | −215,296−78.0% | Reduced |
| Prudential Financial Inc | 59,800 | $29.8K | 0.00% | +14,400+31.7% | Added |
| Jane Street Group, LLC | 58,732 | $29.2K | 0.00% | −385,858−86.8% | Reduced |
| Marshall Wace, LLP | 54,161 | $27.1K | 0.00% | −85,546−61.2% | Reduced |
| HarbourVest Partners LLC | 29,018 | $14.5K | 0.01% | 00.0% | Unchanged |
| Parametrica Management Ltd | 27,840 | $13.9K | 0.02% | 00.0% | Unchanged |
| XTX Topco Ltd | 27,558 | $13.7K | 0.00% | +27,558 | New |
| Bluefin Capital Management, LLC | 24,018 | $12.0K | 0.01% | +24,018 | New |
| HRT Financial LP | 18,113 | $9.00K | 0.00% | −92,951−83.7% | Reduced |
| Point72 Asia (Singapore) Pte. Ltd. | 17,861 | $8.89K | 0.00% | −19,023−51.6% | Reduced |
| Qube Research & Technologies Ltd | 17,501 | $8.71K | 0.00% | −50,236−74.2% | Reduced |
| Quadrant Private Wealth Management, LLC | 15,286 | $7.61K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 13,116 | $6.53K | 0.00% | −9,246−41.3% | Reduced |
| Jain Global LLC | 11,241 | $5.60K | 0.00% | −29,035−72.1% | Reduced |
| AQR Capital Management LLC | 10,660 | $5.31K | 0.00% | −136,508−92.8% | Reduced |
| Advisors Asset Management, Inc. | 8,412 | $4.19K | 0.00% | −86−1.0% | Reduced |
| Citigroup Inc | 2,210 | $1.10K | 0.00% | −13,763−86.2% | Reduced |
| JPMorgan Chase & Co | 1,593 | $793 | 0.00% | −1,044−39.6% | Reduced |
| SBI Securities Co., Ltd. | 1,530 | $762 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 1,478 | $736 | 0.00% | −2,203−59.8% | Reduced |
| Point72 (DIFC) Ltd | 1,064 | $530 | 0.00% | −685−39.2% | Reduced |
| Nisa Investment Advisors, LLC | 883 | $440 | 0.00% | −379−30.0% | Reduced |
| Bank of America Corp | 598 | $298 | 0.00% | −2,692−81.8% | Reduced |
| Mark Sheptoff Financial Planning, LLC | 500 | $249 | 0.00% | 00.0% | Unchanged |
| Advisory Services Network, LLC | 407 | $203 | 0.00% | +407 | New |
| UBS Group AG | 337 | $168 | 0.00% | −27,689−98.8% | Reduced |
| Morgan Stanley | 118 | $59 | 0.00% | −11,222−99.0% | Reduced |
| SRS Capital Advisors, Inc. | 99 | $49 | 0.00% | +99 | New |
| Optiver Holding B.V. | 32 | $16 | 0.00% | +32 | New |
| EverSource Wealth Advisors, LLC | 28 | $14 | 0.00% | −427−93.8% | Reduced |
| IFP Advisors, Inc | 6 | $3 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 1 | $0 | 0.00% | −12,196−100.0% | Reduced |
| CWM, LLC | 254 | $0 | 0.00% | −7,897−96.9% | Reduced |
| Royal Bank of Canada | 71 | $0 | 0.00% | −28−28.3% | Reduced |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −163,377−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −89,975−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −62,947−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −26,700−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −22,419−100.0% | Sold out |
| Abel Hall, LLC | 0 | $0 | 0.00% | −17,582−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,767−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −10,176−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −6,274−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −1,978−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −861−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −266−100.0% | Sold out |
| Essential Partners LLC | 0 | $0 | 0.00% | −119−100.0% | Sold out |